Indaptus Therapeutics, Inc. (INDP)
NASDAQ: INDP · Real-Time Price · USD
3.770
0.00 (0.00%)
Sep 24, 2026, 10:00 AM EDT - Market open
Indaptus Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 7.55 | 8.51 | 5.79 | 13.36 | 9.63 | 39.13 |
Short-Term Investments | 4 | - | - | - | 16.81 | - |
Cash & Short-Term Investments | 11.55 | 8.51 | 5.79 | 13.36 | 26.43 | 39.13 |
Cash Growth | 87.63% | 47.02% | -56.69% | -49.45% | -32.45% | 2289.75% |
Other Receivables | - | - | - | - | - | 0.02 |
Receivables | - | - | - | - | - | 0.02 |
Prepaid Expenses | 0.41 | 0.41 | 0.68 | 0.62 | 0.73 | 0.96 |
Other Current Assets | 0.03 | 0.39 | 0.15 | 0.02 | 0.08 | 0.28 |
Total Current Assets | 11.99 | 9.31 | 6.62 | 14 | 27.24 | 40.39 |
Property, Plant & Equipment | - | - | 0.08 | 0.17 | 0.08 | 0.17 |
Other Long-Term Assets | - | - | 0.64 | 0.75 | 0.74 | 0.02 |
Total Assets | 11.99 | 9.31 | 7.34 | 14.92 | 28.06 | 40.58 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 0.51 | 0.54 | 0.87 | 0.81 | 1.38 | 2.54 |
Accrued Expenses | 0.11 | 5.61 | 2.44 | 1.87 | 1.97 | 1.97 |
Current Portion of Leases | - | - | 0.08 | 0.1 | 0.08 | 0.1 |
Total Current Liabilities | 0.62 | 6.16 | 3.39 | 2.77 | 3.43 | 4.6 |
Long-Term Leases | - | - | - | 0.07 | - | 0.07 |
Total Liabilities | 0.62 | 6.16 | 3.39 | 2.85 | 3.43 | 4.68 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 1.33 | 0.02 | 0 | 0.08 | 0.08 | 0.08 |
Additional Paid-In Capital | 95.66 | 84.41 | 64.38 | 57.41 | 54.44 | 51.49 |
Retained Earnings | -85.62 | -81.29 | -60.44 | -45.42 | -29.99 | -15.67 |
Comprehensive Income & Other | - | - | - | - | 0.1 | - |
Total Common Equity | 11.37 | 3.14 | 3.94 | 12.08 | 24.63 | 35.9 |
Shareholders' Equity | 11.37 | 3.15 | 3.94 | 12.08 | 24.63 | 35.9 |
Total Liabilities & Equity | 11.99 | 9.31 | 7.34 | 14.92 | 28.06 | 40.58 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | - | - | 0.08 | 0.18 | 0.08 | 0.17 |
Net Cash (Debt) | 11.55 | 8.51 | 5.7 | 13.19 | 26.35 | 38.96 |
Net Cash Growth | - | 49.19% | -56.76% | -49.96% | -32.37% | 2279.41% |
Net Cash Per Share | 0.35 | 8.81 | 17.07 | 43.95 | 89.31 | 266.70 |
Filing Date Shares Outstanding | 133.24 | 2.24 | 0.52 | 0.3 | 0.3 | 0.29 |
Total Common Shares Outstanding | 133.24 | 2.17 | 0.43 | 0.3 | 0.3 | 0.29 |
Working Capital | 11.37 | 3.15 | 3.22 | 11.22 | 23.81 | 35.78 |
Book Value Per Share | 0.09 | 1.45 | 9.19 | 40.25 | 82.09 | 121.71 |
Tangible Book Value | 11.37 | 3.14 | 3.94 | 12.08 | 24.63 | 35.9 |
Tangible Book Value Per Share | 0.09 | 1.45 | 9.19 | 40.25 | 82.09 | 121.71 |